Skip to content

Antibiotic Regimens Tailored by Clinical Pharmacist Suppored by Intensivist Enhanced Rational Use of Antibiotics

Antibiotic Regimens Tailored by Clinical Pharmacist Suppored by Intensivist Enhanced Rational Use of Antibiotics

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04931914
Enrollment
300
Registered
2021-06-18
Start date
2020-01-04
Completion date
2020-12-25
Last updated
2022-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Brief summary

adding pharmaceutical services to patient care and changing the professional activity of pharmacists from drug-focused to patient-oriented care,in the current study, clinical pharmacists will be assigned to monitor pharmacotherapy regimens, participate in patient care, and cooperate in educating the staff and evaluating care.

Detailed description

During the intervention period, the pharmacist attended daily unit rounds with ICU intensivist with a focus on optimization of antibiotic regimens. Pharmacist consultative services were also available by phone calls 24 hours x 7 days if needed. For every patient surgical prophylactic antibiotic initiated immediately before surgery and continued for 48 hours following surgery. Antibiotic therapy had given as either directed or empiric. Directed therapy was defined as treatment of a documented infection based on culture and sensitivity. Empiric therapy was defined as any antibiotic therapy administered when no documented infection was present, and the patient had clinically suspected infection following surgery. Empiric antibiotic administration was required in majority of our SICU patients. Antibiotics had given after exclusion of allergy by history and intradermal sensitivity test.

Interventions

OTHERClinical pharmacy sharing in the patient care regimen

antibiotic regimens will be directed by a trained clinical pharmacist recommendation and supported by intensivist.

Sponsors

University of Alexandria
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* all admitted patients to the ICU between age 18-80 years old

Exclusion criteria

* Patient admitted for less than 24 hours (including deaths and transfers) will be excluded from the study. Pediatric patients weighted less than kilograms.

Design outcomes

Primary

MeasureTime frameDescription
Antibiotics consumption1 yearconsumption will be counted as number of defined daily doses (DDD), expressed as DDD per 100 patient-days
Average length of stay1 yearthe average number of days that patients spent in SICU.
Mortality rate1 yearThe number of deaths of patients admitted to SICU, divided by the number of admissions.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026